logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shailender Bhatia

University of Washington School of Medicine
H指数:57
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma

将工程化自体T细胞重编程以克服 Merkel细胞癌患者的耐药性

Science Translational Medicine
IF14.6
2026-09-090
PRE
Yuta Asano; Joshua R. Veatch; Cheng-Jung Sung; Tzu-Hao Tang; Francesco Mazziotta; Seiji Natsuki; Megan McAfee; Jakob Bakhtiari; Bo Lee; Lauren Martin; Alessandro Rizzi; Tianzi Zhang; Colton W. Smith; Kelly G. Paulson; Thomas M. Schmitt; Evan W. Newell; Anna E. Elz; Daniel G. Chen; Yapeng Su; Heather H. Gustafson; Cecilia C. S. Yeung; Brandon Seaton; Daniel Hunter; David M. Koelle; Shailender Bhatia; Evan T. Hall; Valentin Voillet; Jianhong Cao; Ted Gooley; Philip D. Greenberg; Raphael Gottardo; Shannon K. Oda; Paul Nghiem; Aude G. Chapuis
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management

循环肿瘤DNA水平与 Merkel cell carcinoma 的临床复发时间相关：对患者的管理意义

Journal of the American Academy of Dermatology
IF11.8
2025-10-100
PRE
Tomoko Akaike; Manisha Thakuria; Ann W. Silk; Daniel S. Hippe; Peter Y. Ch’en; Song Youn Park; Nicole M. Urman; Meliea W. Chiu; Hannah Kim; Emily Y. Kim; Evan T. Hall; Shailender Bhatia; Sunil Reddy; Michael Krainock; Alexey Aleshin; Jacob S. Choi; Kenneth Tsai; Sue S. Yom; Siegrid S. Yu; Jaehyuk Choi; Sunandana Chandra; Paul T. Nghiem; Lisa C. Zaba
Concurrent treatment with transarterial immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanoma

经动脉免疫栓塞术联合全身免疫检查点抑制剂对肝转移灶进行同步治疗，以克服眼黑色素瘤肝转移患者的免疫逃逸。

cancer immunology immunotherapy
IF0
2025-07-150
OA
Natalie J. Miller; Sharon W. Kwan; Jacob B. Leary; Daniel S. Hippe; William McCamy; Joshua R. Veatch; Evan T. Hall; Wayne L. Monsky; Shailender Bhatia
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2024-10-230
PRE
Mcgillivray, Erin; Ashouri, Karam; Chatziioannou, Eftychia; Gallegos, Jesus Antonio Ocejo; Zarka, Jabra; Kechter, Jacob; Hwang, Angelina S.; Zhang, Kevin; Barros, Milton; Yeh, Justin; Okazaki, Ian; Crocker, Andrew B.; Maeda, Takuya; Park, Soo J.; Choi, Jacob; Andreoli, Mia; Darwish, Tarneem; Savage, David J.; Kim, Kevin B.; Gupta, Jayant; Shen, James; Shirai, Keisuke; Choi, April; Pai, Lori; Vazquez, Vinicius de Lima; Moser, Justin; Amaral, Teresa; Aya, Leonel F. Hernandez; Lutzky, Jose; Najjar, Yana G.; Costello, Collin M.; Mangold, Aaron R.; Bhatia, Shailender; Gibney, Geoffrey T.; Farma, Jeffrey M.; Daniels, Gregory A.; Sosman, Jeffrey; Chandra, Sunandana; Mangla, Ankit; Bollin, Kathryn; Possik, Patricia Abrao; Robles-Espinoza, Carla Daniela; Ito, Fumito; In, Gino K.
Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-07-018
PRE
Swetter, Susan M.; Johnson, Douglas; Albertini, Mark R.; Barker, Christopher A.; Bateni, Sarah; Baumgartner, Joel; Bhatia, Shailender; Bichakjian, Christopher; Boland, Genevieve; Chandra, Sunandana; Chmielowski, Bartosz; Dimaio, Dominick; Dronca, Roxana; Fields, Ryan C.; Fleming, Martin D.; Galan, Anjela; Guild, Samantha; Hyngstrom, John; Karakousis, Giorgos; Kendra, Kari; Kiuru, Maija; Lange, Julie R.; Lanning, Ryan; Logan, Theodore; Olson, Daniel; Olszanski, Anthony J.; Ott, Patrick A.; Ross, Merrick I.; Rothermel, Luke; Salama, April K.; Sharma, Rohit; Skitzki, Joseph; Smith, Emily; Tsai, Katy; Wuthrick, Evan; Xing, Yan; McMillian, Nicole; Espinosa, Sara
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study
CLINICAL CANCER RESEARCH
IF10.2
2022-10-2588
OA
Meric-Bernstam, Funda; Sweis, Randy F.; Kasper, Stefan; Hamid, Omid; Bhatia, Shailender; Dummer, Reinhard; Stradella, Agostina; Long, Georgina, V; Spreafico, Anna; Shimizu, Toshio; Steeghs, Neeltje; Luke, Jason J.; McWhirter, Sarah M.; Mueller, Thomas; Nair, Nitya; Lewis, Nancy; Chen, Xinhui; Bean, Andrew; Kattenhorn, Lisa; Pelletier, Marc; Sandhu, Shahneen
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2022-07-2815
OAAI
Silk, Ann W.; Barker, Christopher A.; Bhatia, Shailender; Bollin, Kathryn B.; Chandra, Sunandana; Eroglu, Zeynep; Gastman, Brian R.; Kendra, Kari L.; Kluger, Harriet; Lipson, Evan J.; Madden, Kathleen; Miller, David M.; Nghiem, Paul; Pavlick, Anna C.; Puzanov, Igor; Rabinowits, Guilherme; Ruiz, Emily S.; Sondak, Vernon K.; Tavss, Edward A.; Tetzlaff, Michael T.; Brownell, Isaac
Management of Immunotherapy-Related Toxicities, Version 1.2022

免疫疗法相关毒性的管理，1.2022版

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2022-04-01226
OA
Thompson, John A.; Schneider, Bryan J.; Brahmer, Julie; Achufusi, Amaka; Armand, Philippe; Berkenstock, Meghan K.; Bhatia, Shailender; Budde, Lihua E.; Chokshi, Saurin; Davies, Marianne; Elshoury, Amro; Gesthalter, Yaron; Hegde, Aparna; Jain, Michael; Kaffenberger, Benjamin H.; Lechner, Melissa G.; Li, Tianhong; Marr, Alissa; McGettigan, Suzanne; McPherson, Jordan; Medina, Theresa; Mohindra, Nisha A.; Olszanski, Anthony J.; Oluwole, Olalekan; Patel, Sandip P.; Patil, Pradnya; Reddy, Sunil; Ryder, Mabel; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A.; Wang, Yinghong; Zaha, Vlad G.; Lyons, Megan; Dwyer, Mary; Hang, Lisa
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up

先前接受过治疗的转移性Merkel细胞癌患者的Avelumab (标枪默克尔200): 经过> 5年的随访后更新了总体生存数据

ESMO OPEN
IF8.3
2021-12-0132
OAAI
D'Angelo, S. P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I; Lebbe, C.; Lewis, K. D.; Linette, G. P.; Milella, M.; Xiong, H.; Guezel, G.; Nghiem, P. T.
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2021-04-2077
OAAI
Nghiem, Paul; Bhatia, Shailender; Lipson, Evan J.; Sharfman, William H.; Kudchadkar, Ragini R.; Brohl, Andrew S.; Friedlander, Philip A.; Daud, Adil; Kluger, Harriet M.; Reddy, Sunil A.; Boulmay, Brian C.; Riker, Adam; Burgess, Melissa A.; Hanks, Brent A.; Olencki, Thomas; Kendra, Kari; Church, Candice; Akaike, Tomoko; Ramchurren, Nirasha; Shinohara, Michi M.; Salim, Bob; Taube, Janis M.; Jensen, Erin; Kalabis, Mizuho; Fling, Steven P.; Homet Moreno, Blanca; Sharon, Elad; Cheever, Martin A.; Topalian, Suzanne L.

研究方向

暂未获取到该数据
P
Paul Nghiem
H 指数:79论文数:642被引数:2.3万
J
John A. Thompson
H 指数:54论文数:174被引数:1.7万
U
Upendra Parvathaneni
H 指数:31论文数:216被引数:3,669
J
Jayasri G. Iyer
H 指数:27论文数:137被引数:4,226
K
Kelly G. Paulson
H 指数:33论文数:187被引数:5,448
A
Aude G. Chapuis
H 指数:30论文数:189被引数:4,720
A
Astrid Blom
H 指数:26论文数:104被引数:3,015
J
John A. Thompson
H 指数:51论文数:206被引数:2.2万
W
William H. Sharfman
H 指数:46论文数:129被引数:3.0万
D
Daniel S. Hippe
H 指数:47论文数:467被引数:7,625